Stefan Schaeren

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Atlantoaxial osteoarthritis: case series and review of the literature
    Stefan Schaeren
    University Hospital, Dept of Orthopedic Surgery, Spitalstr 21, Basel, Switzerland
    Eur Spine J 14:501-6. 2005
  2. ncbi A computer touch-screen version of the North American Spine Society outcome assessment instrument for the lumbar spine
    S Schaeren
    The University Hospital, Basel, Switzerland
    J Bone Joint Surg Br 87:201-4. 2005
  3. ncbi Minimum four-year follow-up of spinal stenosis with degenerative spondylolisthesis treated with decompression and dynamic stabilization
    Stefan Schaeren
    Center for Musculoskeletal Diseases Spine, University Hospital, Basel, Switzerland
    Spine (Phila Pa 1976) 33:E636-42. 2008
  4. ncbi Assessment of nerve damage using a novel ultrasonic device for bone cutting
    Stefan Schaeren
    Orthopedic Surgery, University Hospital, Basel, Switzerland
    J Oral Maxillofac Surg 66:593-6. 2008
  5. ncbi Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c
    Nunzia Di Maggio
    Departments of Surgery and of Biomedicine, Basel University Hospital, Hebelstrasse 20, Basel, Switzerland
    Stem Cells 30:1455-64. 2012
  6. ncbi Effect of bone sialoprotein coating of ceramic and synthetic polymer materials on in vitro osteogenic cell differentiation and in vivo bone formation
    Stefan Schaeren
    Department of Surgery and Biomedicine, University Hospital Basel, Basel, Switzerland
    J Biomed Mater Res A 92:1461-7. 2010
  7. ncbi In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells
    Claude Jaquiery
    Departments of Surgery, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
    Ann Surg 242:859-67, discussion 867-8. 2005
  8. ncbi Percutaneous cervical vertebroplasty in a multifunctional image-guided therapy suite: hybrid lateral approach to C1 and C4 under CT and fluoroscopic guidance
    R W Huegli
    Department of Radiology, University Hospital of Basel, Basel, Switzerland
    Cardiovasc Intervent Radiol 28:649-52. 2005
  9. ncbi Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells
    Chiara Bocelli-Tyndall
    University Hospital Basel and University of Basel, Basel, Switzerland
    Arthritis Rheum 62:3815-25. 2010
  10. ncbi Differentiation-dependent up-regulation of BMP-2, TGF-beta1, and VEGF expression by FGF-2 in human bone marrow stromal cells
    Jian Farhadi
    Department of Surgery, University Hospital Basel, Basel, Switzerland
    Plast Reconstr Surg 116:1379-86. 2005

Detail Information

Publications13

  1. ncbi Atlantoaxial osteoarthritis: case series and review of the literature
    Stefan Schaeren
    University Hospital, Dept of Orthopedic Surgery, Spitalstr 21, Basel, Switzerland
    Eur Spine J 14:501-6. 2005
    ..All five patients would undergo this surgery for the same condition again. C1-C2 fusion effectively relieves occipitocervical pain in AAOA non responsive to conservative treatment...
  2. ncbi A computer touch-screen version of the North American Spine Society outcome assessment instrument for the lumbar spine
    S Schaeren
    The University Hospital, Basel, Switzerland
    J Bone Joint Surg Br 87:201-4. 2005
    ..Our data indicate that the touch-screen format is comparable to the paper form. It may improve follow-up in clinical practice and research by meeting patients' preferences and minimising administrative work...
  3. ncbi Minimum four-year follow-up of spinal stenosis with degenerative spondylolisthesis treated with decompression and dynamic stabilization
    Stefan Schaeren
    Center for Musculoskeletal Diseases Spine, University Hospital, Basel, Switzerland
    Spine (Phila Pa 1976) 33:E636-42. 2008
    ..Prospective clinical study...
  4. ncbi Assessment of nerve damage using a novel ultrasonic device for bone cutting
    Stefan Schaeren
    Orthopedic Surgery, University Hospital, Basel, Switzerland
    J Oral Maxillofac Surg 66:593-6. 2008
  5. ncbi Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c
    Nunzia Di Maggio
    Departments of Surgery and of Biomedicine, Basel University Hospital, Hebelstrasse 20, Basel, Switzerland
    Stem Cells 30:1455-64. 2012
    ..In conclusion, our data show a niche/progenitor organization in vitro, in which the BM adherent fraction provides a self-renewing microenvironment for primitive NAMP...
  6. ncbi Effect of bone sialoprotein coating of ceramic and synthetic polymer materials on in vitro osteogenic cell differentiation and in vivo bone formation
    Stefan Schaeren
    Department of Surgery and Biomedicine, University Hospital Basel, Basel, Switzerland
    J Biomed Mater Res A 92:1461-7. 2010
    ....
  7. ncbi In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells
    Claude Jaquiery
    Departments of Surgery, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
    Ann Surg 242:859-67, discussion 867-8. 2005
    ..To compare the in vitro osteogenic differentiation and in vivo ectopic bone forming capacity of human bone marrow stromal cells (BMSCs) and jaw periosteal cells (JPCs), and to identify molecular predictors of their osteogenic capacity...
  8. ncbi Percutaneous cervical vertebroplasty in a multifunctional image-guided therapy suite: hybrid lateral approach to C1 and C4 under CT and fluoroscopic guidance
    R W Huegli
    Department of Radiology, University Hospital of Basel, Basel, Switzerland
    Cardiovasc Intervent Radiol 28:649-52. 2005
    ..A hybrid approach for vertebroplasty in a MIGTS appears to be safe and feasible and might be indicated in selected cases for difficult accessible lesions...
  9. ncbi Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells
    Chiara Bocelli-Tyndall
    University Hospital Basel and University of Basel, Basel, Switzerland
    Arthritis Rheum 62:3815-25. 2010
    ....
  10. ncbi Differentiation-dependent up-regulation of BMP-2, TGF-beta1, and VEGF expression by FGF-2 in human bone marrow stromal cells
    Jian Farhadi
    Department of Surgery, University Hospital Basel, Basel, Switzerland
    Plast Reconstr Surg 116:1379-86. 2005
    ..These findings prompt for in vivo investigations on the delivery of FGF-2 for the temporally/functionally regulated enhancement of bone marrow stromal cell-based bone induction...
  11. ncbi The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells
    Alessandra Braccini
    Department of Surgery, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland
    J Tissue Eng Regen Med 1:60-5. 2007
    ..Possible ways to quantify the density of clonogenic cells as a quality control parameter to predict potency of BMSC-based constructs are discussed...
  12. ncbi Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells
    Fabian von Knoch
    Biomaterials Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biomaterials 26:6941-9. 2005
    ....
  13. ncbi Dynamic stabilization in addition to decompression for lumbar spinal stenosis with degenerative spondylolisthesis
    Klaus John Schnake
    Center for Musculosceletal Surgery, Department of Orthopedic Surgery and Traumatology, , Berlin, Germany
    Spine 31:442-9. 2006
    ..It maintains enough stability to prevent further progression of spondylolisthesis or instability. With the Dynesys system, no bone grafting is necessary, therefore, donor site morbidity can be avoided...